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Tubercle bacilli with reduced metabolic 
activity are present in clinical samples, 
including sputum, in large numbers. 
These slowly replicating or nonreplicat-
ing bacilli are more able to tolerate anti-
biotics and resistant to multiple stresses, 
but their role, if any, in the transmission 
of tuberculosis is less well established.
In this issue of The Journal of Infectious 
Diseases, Datta et al [1] report mycobac-
terial counts, after staining with aur-
amine or fluorescein diacetate, in pooled 
sputum specimens collected overnight 
at the time of diagnosis from 35 patients 
with tuberculosis who tested highly posi-
tive for acid-fast bacilli. Close household 
contacts of these patients were moni-
tored for 6 years. Strikingly, the close 
contacts of patients with a higher pro-
portion of fluorescein diacetate micros-
copy–negative cells were significantly 
more likely to develop tuberculosis. This 
result might be considered unexpected, 
as fluorescein diacetate microscopy has 
been successfully used to follow myco-
bacterial killing during treatment by 
Salim et al [2], as well as by Datta et al [3]. 
Dead mycobacterium cells are auramine 
positive and fluorescein diacetate nega-
tive. These results may be less striking to 
those more familiar with tuberculosis, 
who will probably immediately think 
of latent/dormant/fat lazy mycobacteria 
[4]. Thus, this careful microscopy-based 
study with detailed follow up, performed 
over years, provides clinical data that 
suggest the variously named pheno-
type of Mycobacterium tuberculosis with 
reduced metabolic activity is fluorescein 
diacetate negative and may indeed be the 
most infectious form. Further studies, 
such as those investigating any correla-
tions between the proportion of acid-
fast bacilli–positive and FOA-negative 
cells in cases and the probability of 
tuberculin skin test or IGRA positivity 
among their close contacts, as suggested 
by Datta et al, would be a logical follow 
up to this work.
It is widely accepted that a dormant 
phenotype is critical in the life cycle of 
M.  tuberculosis. Latent mycobacteria are 
the likely reason for long periods of sub-
clinical infection in many contacts and 
also why such long treatment is required 
to achieve lasting cure. The cells pres-
ent in a normal M.  tuberculosis labora-
tory culture are indeed visibly different 
from those seen in patient samples [4], 
and in an attempt to study this pheno-
type in vitro, the Wayne model [5] and 
related culture methods have been widely 
applied. The elegant study by Datta et al 
suggests that that the fluorescein diace-
tate–negative cells are also more suited to 
establishing new infections, presumably 
because they survive longer in the envi-
ronment and/or more efficiently resist 
the initial assault by the host’s immune 
system.
In the study of Datta et al, a median of 
2069 bacteria/μL stained positive by aur-
amine, but only a median of 119 bacte-
ria/μL were FOA positive; thus, the vast 
majority of mycobacterial cells stained 
by auramine in this study were FOA 
negative. Quantitative cultures recov-
ered an even smaller proportion of the 
auramine-positive cells (median, 40 col-
ony-forming units/μL vs 2069 bacteria/
μL). The impact of sputum decontami-
nation, which is required to prevent the 
overgrowth of other species of bacteria, is 
difficult to quantify, but the proportions 
of FOA-negative uncultivable bacteria 
are impressive. Others have also shown 
that around 90% of the bacilli in sputum 
are persisters that are difficult to recover 
in culture [6], adding credibility to these 
numbers.
Variations in the proportion of these 
FAO-negative cells are presumably influ-
enced by the host disease status and the 
infecting mycobacterial strain. It is tempt-
ing to speculate that the differing propen-
sities to enter a latent state observed in 
certain mycobacterial lineages [7, 8] may 
be one of the factors explaining their suc-
cess. Attacking M. tuberculosis bacilli by 
disrupting the apparently critical balance 
between an active and a latent phenotype 
is also being considered [9].
In conclusion, the striking findings by 
Datta et al, as well as a method to identify 
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the most infectious patients and target 
their contacts for preventive therapy, 
should also stimulate efforts to develop 
a more complete understanding of the 
bacteriological details of fat lazy, latent, 
fluorescein diacetate–negative bacteria.
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